Sutro Biopharma Inc

Research Sutro Biopharma Inc (STRO) on Bullrun: market cap USD 552.62M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSTRO
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 552.62M
• Financial periodFY2025
• RevenueUSD 102.48M
• Revenue growth65.2%
• Net income-USD 191.00M

Valuation Snapshot

latest market cap is USD 552.62M.

About Sutro Biopharma Inc

Sutro Biopharma, Inc. operates as an oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF; and site-specific conjugation platform, XpressCF+.

Frequently asked questions

What is Sutro Biopharma Inc's market cap?

Sutro Biopharma Inc's market capitalization is USD 552.62M.

What does Sutro Biopharma Inc do?

Sutro Biopharma, Inc. operates as an oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF; and site-specific conjugation platform, XpressCF+.